Literature DB >> 12487509

Improved haemoglobin concentrations with IV darbepoetin alfa--case studies of haemodialysis patients.

A Thiele1, M Wittner.   

Abstract

This paper presents two case histories of patients receiving intravenous (IV) darbepoetin alfa for the treatment of anaemia in chronic renal failure. The paper sets these cases against the general clinical picture of patients receiving intravenous darbepoetin alfa in our renal unit.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12487509     DOI： 10.1185/030079902125001182

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


  1 in total

1.  Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients.

Authors:  Georgios Bristoyiannis; Nikolaos Germanos; Dimitrios Grekas; Christos Hatzidimitriou; Christos Iatrou; Dimitrios Memmos; Spiros Moutafis; Konstantinos Papachristoforou; Antonis Papadoniou; Michalis Pappas; George A Sakellariou; Kostas C Siamopoulos; Konstantinos Sombolos; Kiriaki Stamatelou; Charalambos P Stathakis; Georgios Stavgiannoudakis; Spiros Stratigis; Christos Syrganis; Dimitris Tsakiris; Dimitris Valis; Jannis G Vlahojannis; Dimosthenis Vlassopoulos
Journal:  Curr Ther Res Clin Exp       Date:  2005-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.